Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Adaptation of a plant pathogen to partial host resistance: selection for greater aggressiveness in grapevine downy mildew.

Delmas CE, Fabre F, Jolivet J, Mazet ID, Richart Cervera S, Delière L, Delmotte F.

Evol Appl. 2016 Feb 24;9(5):709-25. doi: 10.1111/eva.12368. eCollection 2016 Jun.

2.

Epistasis between antibiotic resistance mutations and genetic background shape the fitness effect of resistance across species of Pseudomonas.

Vogwill T, Kojadinovic M, MacLean RC.

Proc Biol Sci. 2016 May 11;283(1830). pii: 20160151. doi: 10.1098/rspb.2016.0151.

3.

The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa.

Qi Q, Toll-Riera M, Heilbron K, Preston GM, MacLean RC.

Proc Biol Sci. 2016 Jan 13;283(1822). pii: 20152452. doi: 10.1098/rspb.2015.2452.

4.

Evolution of Resistance to Continuously Increasing Streptomycin Concentrations in Populations of Escherichia coli.

Spagnolo F, Rinaldi C, Sajorda DR, Dykhuizen DE.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1336-42. doi: 10.1128/AAC.01359-15.

5.

Evolutionary rescue by compensatory mutations is constrained by genomic and environmental backgrounds.

Filteau M, Hamel V, Pouliot MC, Gagnon-Arsenault I, Dubé AK, Landry CR.

Mol Syst Biol. 2015 Oct 12;11(10):832. doi: 10.15252/msb.20156444.

6.

Fluoroquinolone Impact on Nasal Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Colonization Durations in Neurologic Long-Term-Care Facilities.

Couderc C, Thiébaut AC, Lawrence C, Bouchiat C, Herrmann JL, Salomon J, Guillemot D; Antibiotic Use and Staphylococcus aureus Resistant to Antibiotics Study Group.

Antimicrob Agents Chemother. 2015 Dec;59(12):7621-8. doi: 10.1128/AAC.01338-15. Epub 2015 Sep 28.

7.

Potential for adaptation overrides cost of resistance.

Moura de Sousa J, Sousa A, Bourgard C, Gordo I.

Future Microbiol. 2015;10(9):1415-31. doi: 10.2217/fmb.15.61. Epub 2015 Sep 7.

8.

Isolated cell behavior drives the evolution of antibiotic resistance.

Artemova T, Gerardin Y, Dudley C, Vega NM, Gore J.

Mol Syst Biol. 2015 Jul 29;11(7):822. doi: 10.15252/msb.20145888.

9.

Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance.

Obolski U, Stein GY, Hadany L.

PLoS Comput Biol. 2015 Jun 25;11(6):e1004340. doi: 10.1371/journal.pcbi.1004340. eCollection 2015 Jun.

10.

Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis: A Household-Based Case-Control Study.

Salvatore PP, Becerra MC, Abel zur Wiesch P, Hinkley T, Kaur D, Sloutsky A, Cohen T.

J Infect Dis. 2016 Jan 1;213(1):149-55. doi: 10.1093/infdis/jiv347. Epub 2015 Jun 19.

PMID:
26092854
11.

The potential impact of coinfection on antimicrobial chemotherapy and drug resistance.

Birger RB, Kouyos RD, Cohen T, Griffiths EC, Huijben S, Mina MJ, Volkova V, Grenfell B, Metcalf CJ.

Trends Microbiol. 2015 Sep;23(9):537-44. doi: 10.1016/j.tim.2015.05.002. Epub 2015 May 29. Review. Erratum in: Trends Microbiol. 2015 Nov;23(11):742. Mina, Michael [Corrected to Mina, Michael J].

PMID:
26028590
12.

The fitness costs of antibiotic resistance mutations.

Melnyk AH, Wong A, Kassen R.

Evol Appl. 2015 Mar;8(3):273-83. doi: 10.1111/eva.12196. Epub 2014 Aug 27. Review.

13.

Costs of antibiotic resistance - separating trait effects and selective effects.

Hall AR, Angst DC, Schiessl KT, Ackermann M.

Evol Appl. 2015 Mar;8(3):261-72. doi: 10.1111/eva.12187. Epub 2014 Jul 14. Review.

14.

Public health evolutionary biology of antimicrobial resistance: priorities for intervention.

Baquero F, Lanza VF, Cantón R, Coque TM.

Evol Appl. 2015 Mar;8(3):223-39. doi: 10.1111/eva.12235. Epub 2014 Dec 11.

15.

Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health.

Perron GG, Inglis RF, Pennings PS, Cobey S.

Evol Appl. 2015 Mar;8(3):211-22. doi: 10.1111/eva.12254. Epub 2015 Mar 23.

16.

Limits to compensatory adaptation and the persistence of antibiotic resistance in pathogenic bacteria.

MacLean RC, Vogwill T.

Evol Med Public Health. 2014 Dec 21;2015(1):4-12. doi: 10.1093/emph/eou032. Review.

17.

A genomic and evolutionary approach reveals non-genetic drug resistance in malaria.

Herman JD, Rice DP, Ribacke U, Silterra J, Deik AA, Moss EL, Broadbent KM, Neafsey DE, Desai MM, Clish CB, Mazitschek R, Wirth DF.

Genome Biol. 2014;15(11):511.

18.

Lytic phages obscure the cost of antibiotic resistance in Escherichia coli.

Tazzyman SJ, Hall AR.

ISME J. 2015 Mar 17;9(4):809-20. doi: 10.1038/ismej.2014.176.

19.

A model-guided analysis and perspective on the evolution and epidemiology of antibiotic resistance and its future.

Levin BR, Baquero F, Johnsen PJ.

Curr Opin Microbiol. 2014 Jun;19:83-9. doi: 10.1016/j.mib.2014.06.004. Epub 2014 Jul 11.

20.

Reversibility of antibiotic resistance.

Sundqvist M.

Ups J Med Sci. 2014 May;119(2):142-8. doi: 10.3109/03009734.2014.903323. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk